CORE LABORATORIES N.V. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-10-19: Form 8-K; Period of report 2016-10-19; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2016-10-11: Form 8-K; Period of report 2016-10-11; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2016-09-20: Form 8-K; Period of report 2016-09-20; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2016-07-20: Form 8-K; Period of report 2016-07-20; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2016-10-19 | 8-K | 2016-10-19 | 2.02 Results of Operations and Financial Condition | 2.02 On October 19, 2016, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2016. | clb-2016q3_earningsrelease.htm |
| 2016-10-11 | 8-K | 2016-10-11 | 7.01 Regulation FD Disclosure | 7.01 On October 11, 2016, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on October 21, 2016 and payable November 22, 2016. | clb-8k_dividend4q2016.htm |
| 2016-09-20 | 8-K | 2016-09-20 | 7.01 Regulation FD Disclosure | 7.01 On September 20, 2016, Core Laboratories N.V. (the “Company”) issued a press release announcing that our Chairman and CEO, David M. Demshur, will be speaking at the Johnson Rice Energy Conference in New Orleans, Louisiana on September 21, 2016. | a8k_clb-conference9x20x16.htm |
| 2016-07-20 | 8-K | 2016-07-20 | 2.02 Results of Operations and Financial Condition | 2.02 On July 20, 2016, Core Laboratories N.V. issued a press release announcing its financial results for the second quarter of 2016. | clb-2016q2_earningsrelease.htm |
| 2016-07-07 | 8-K | 2016-07-07 | 7.01 Regulation FD Disclosure | 7.01 On July 7, 2016, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on July 18, 2016 and payable August 15, 2016. | clb-8k_dividend3q2016.htm |
| 2016-05-24 | 8-K | 2016-05-24 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Core Laboratories N.V. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on May 19, 2016 in Amsterdam, The Netherlands. | a2016annualshareholdermeet.htm |
| 2016-05-17 | 8-K | 2016-05-11 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d178293d8k.htm |
| 2016-04-20 | 8-K | 2016-04-20 | 2.02 Results of Operations and Financial Condition | 2.02 On April 20, 2016, Core Laboratories N.V. issued a press release announcing its financial results for the first quarter of 2016. | clb-2016q1_earningsrelease.htm |
| 2016-04-14 | 8-K | 2016-04-14 | 7.01 Regulation FD Disclosure | 7.01 On April 14, 2016, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on May 4, 2016 and payable May 24, 2016. | clb-8k_dividend2q2016.htm |
| 2016-01-27 | 8-K | 2016-01-27 | 2.02 Results of Operations and Financial Condition | 2.02 On January 27, 2016, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2015 and full year ended December 31, 2015. | clb-2015q4_earningsrelease.htm |
| 2016-01-11 | 8-K | 2016-01-11 | 7.01 Regulation FD Disclosure | 7.01 On January 11, 2016, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on January 22, 2016 and payable February 19, 2016. | clb-8k_dividend1q2016.htm |